A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study will compare the relative bioavailability of hydrocodone, acetaminophen, and
promethazine in CL-108 (hydrocodone 7.5mg/ acetaminophen 325 mg/ promethazine 12.5 mg)
manufactured by Charleston Laboratories, Inc. to hydrocodone in Vicoprofen (hydrocodone 7.5
mg /ibuprofen 200 mg), promethazine 12.5 mg, and acetaminophen in Ultracet (tramadol HCl 37.5
mg/acetaminophen 325 mg) under fasted and fed conditions.